Nitric Oxide Induces Angiogenesis and Upregulates αvβ3 Integrin Expression on Endothelial Cells
暂无分享,去创建一个
Simon C Watkins | B. Griffith | D. Stolz | M. Kibbe | T. Billiar | Paul C. Lee | M. Schuchert | L. Shears
[1] Timothy R Billiar,et al. Impaired wound healing and angiogenesis in eNOS-deficient mice. , 1999, American journal of physiology. Heart and circulatory physiology.
[2] H. Granger,et al. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. , 1998, American journal of physiology. Heart and circulatory physiology.
[3] G. Garcı́a-Cardeña,et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.
[4] H. Luk,et al. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody. , 1997, Biochimica et biophysica acta.
[5] T. Billiar,et al. Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. , 1997, Surgery.
[6] R Bicknell,et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. , 1997, The Journal of clinical investigation.
[7] M A Horton,et al. The alpha v beta 3 integrin "vitronectin receptor". , 1997, The international journal of biochemistry & cell biology.
[8] M. Nehls,et al. Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like Proteases , 1997, The Journal of experimental medicine.
[9] Simon C Watkins,et al. Nitric Oxide Protects Cultured Rat Hepatocytes from Tumor Necrosis Factor-α-induced Apoptosis by Inducing Heat Shock Protein 70 Expression* , 1997, The Journal of Biological Chemistry.
[10] P. Campochiaro,et al. Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[11] J. Becker,et al. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. , 1996, The Journal of clinical investigation.
[12] M. Detmar,et al. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. , 1996, The American journal of pathology.
[13] D. Cheresh,et al. Transient functional expression of alphaVbeta 3 on vascular cells during wound repair. , 1996, The American journal of pathology.
[14] David A. Cheresh,et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.
[15] F. Sarkar,et al. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.
[16] D. Cheresh,et al. An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. , 1995, Journal of cell science.
[17] D. Cheresh,et al. Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.
[18] M. Clarke,et al. The Bcl-2 family of proteins: regulators of cell death and survival. , 1994, Trends in cell biology.
[19] S Amerini,et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. , 1994, The Journal of clinical investigation.
[20] E. Brown,et al. Basic Fibroblast Growth Factor Increases Expression of the αvβ3 Integrin Complex on Human Microvascular Endothelial Cells , 1994 .
[21] A. Koch,et al. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[23] R. Kramer,et al. Basic FGF and TGF-beta differentially modulate integrin expression of human microvascular endothelial cells. , 1992, Experimental cell research.
[24] F. Luyten,et al. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. , 1992, Experimental cell research.
[25] G. Laurie,et al. Basement membrane complexes with biological activity. , 1986, Biochemistry.
[26] J. Folkman,et al. ANGIOGENESIS: INITIATION AND CONTROL * , 1982, Annals of the New York Academy of Sciences.
[27] J. Isner,et al. Therapeutic Angiogenesis: A New Frontier for Vascular Therapy , 1996, Vascular medicine.
[28] Ivar Giaever,et al. Podokinesis in endothelial cell migration: role of nitric oxide. , 1998, American journal of physiology. Cell physiology.
[29] H. Granger,et al. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. , 1996, The American journal of physiology.
[30] D. Cheresh,et al. An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularization , 1995 .
[31] A. Passaniti,et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.